Cargando…
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
Tumor cells and the immunosuppressive tumor microenvironment suppress the antitumor activity of T cells through immune checkpoints, including the PD-L1/PD-1 axis. Cytokine-inducible SH2-containing protein (CISH), a member of the suppressor of cytokine signaling (SOCS) family, inhibits JAK-STAT and T...
Autores principales: | Lv, Jiang, Qin, Le, Zhao, Ruocong, Wu, Di, Wu, Zhiping, Zheng, Diwei, Li, Siyu, Luo, Mintao, Wu, Qiting, Long, Youguo, Tang, Zhaoyang, Tang, Yan-Lai, Luo, Xuequn, Yao, Yao, Yang, Li-Hua, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827364/ https://www.ncbi.nlm.nih.gov/pubmed/36654786 http://dx.doi.org/10.1016/j.omto.2022.12.003 |
Ejemplares similares
-
PSCA is a target of chimeric antigen receptor T cells in gastric cancer
por: Wu, Di, et al.
Publicado: (2020) -
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
por: Qin, Le, et al.
Publicado: (2022) -
Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer
por: Zhao, Ruocong, et al.
Publicado: (2021) -
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
por: Lv, Jiang, et al.
Publicado: (2019) -
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies
por: Zheng, Diwei, et al.
Publicado: (2022)